{"version":"1.0","provider_name":"Avalere Health Advisory","provider_url":"https:\/\/advisory.avalerehealth.com","title":"IRA Question of the Week: How Will the Law Impact Plans and PBMs? | Avalere Health Advisory","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"HyjuS9PPe4\"><a href=\"https:\/\/advisory.avalerehealth.com\/insights\/ira-question-of-the-week-how-will-the-law-impact-plans-and-pbms\">IRA Question of the Week: How Will the Law Impact Plans and PBMs?<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/advisory.avalerehealth.com\/insights\/ira-question-of-the-week-how-will-the-law-impact-plans-and-pbms\/embed#?secret=HyjuS9PPe4\" width=\"600\" height=\"338\" title=\"&#8220;IRA Question of the Week: How Will the Law Impact Plans and PBMs?&#8221; &#8212; Avalere Health Advisory\" data-secret=\"HyjuS9PPe4\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n<\/script>\n","thumbnail_url":"https:\/\/advisory.avalerehealth.com\/wp-content\/uploads\/2020\/03\/John_Neal_600x400-e1593009134879.jpg","thumbnail_width":600,"thumbnail_height":400,"description":"[vc_row][vc_column][vc_column_text]The Inflation Reduction Act (IRA) is bringing landmark policy changes to the healthcare industry, raising important questions about\u00a0drug pricing,\u00a0health plan design, and\u00a0investment. In this new series, Avalere will be answering the pressing questions shaping healthcare stakeholders\u2019 strategic decision making as the IRA is implemented. In this installment, Avalere experts discuss how Part D redesign and&hellip;"}